BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18461092)

  • 1. Reconstructing exposures from small samples using physiologically based pharmacokinetic models and multiple biomarkers.
    Mosquin PL; Licata AC; Liu B; Sumner SC; Okino MS
    J Expo Sci Environ Epidemiol; 2009 Mar; 19(3):284-97. PubMed ID: 18461092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative chlorpyrifos pharmacokinetics via multiple routes of exposure and vehicles of administration in the adult rat.
    Smith JN; Campbell JA; Busby-Hjerpe AL; Lee S; Poet TS; Barr DB; Timchalk C
    Toxicology; 2009 Jun; 261(1-2):47-58. PubMed ID: 19397948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstructing week-long exposures to volatile organic compounds using physiologically based pharmacokinetic models.
    Roy A; Georgopoulos PG
    J Expo Anal Environ Epidemiol; 1998; 8(3):407-22. PubMed ID: 9679220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating absorbed dose of pesticides in a field setting using biomonitoring data and pharmacokinetic models.
    Scher DP; Sawchuk RJ; Alexander BH; Adgate JL
    J Toxicol Environ Health A; 2008; 71(6):373-83. PubMed ID: 18246497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of chlorpyrifos exposures and urinary 3,5,6-trichloro-2-pyridinol levels among termiticide applicators.
    Hines CJ; Deddens JA
    Ann Occup Hyg; 2001 Jun; 45(4):309-21. PubMed ID: 11378153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study.
    Sohn MD; McKone TE; Blancato JN
    J Expo Anal Environ Epidemiol; 2004 May; 14(3):204-13. PubMed ID: 15141149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorpyrifos PBPK/PD model for multiple routes of exposure.
    Poet TS; Timchalk C; Hotchkiss JA; Bartels MJ
    Xenobiotica; 2014 Oct; 44(10):868-81. PubMed ID: 24839995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agreement of pesticide biomarkers between morning void and 24-h urine samples from farmers and their children.
    Scher DP; Alexander BH; Adgate JL; Eberly LE; Mandel JS; Acquavella JF; Bartels MJ; Brzak KA
    J Expo Sci Environ Epidemiol; 2007 Jul; 17(4):350-7. PubMed ID: 16788681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a non-invasive biomonitoring approach to determine exposure to the organophosphorus insecticide chlorpyrifos in rat saliva.
    Timchalk C; Campbell JA; Liu G; Lin Y; Kousba AA
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):217-25. PubMed ID: 17118418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a source-to-outcome model for dietary exposures to insecticide residues: an example using chlorpyrifos.
    Hinderliter PM; Price PS; Bartels MJ; Timchalk C; Poet TS
    Regul Toxicol Pharmacol; 2011 Oct; 61(1):82-92. PubMed ID: 21722690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal variability of urinary levels of nonpersistent insecticides in adult men.
    Meeker JD; Barr DB; Ryan L; Herrick RF; Bennett DH; Bravo R; Hauser R
    J Expo Anal Environ Epidemiol; 2005 May; 15(3):271-81. PubMed ID: 15340359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian population analysis of a washin-washout physiologically based pharmacokinetic model for acetone.
    Mörk AK; Jonsson F; Johanson G
    Toxicol Appl Pharmacol; 2009 Nov; 240(3):423-32. PubMed ID: 19660484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of biomarkers in volunteer studies: The biological component.
    Spaan S; Fransman W; Warren N; Cotton R; Cocker J; Tielemans E
    Toxicol Lett; 2010 Oct; 198(2):144-51. PubMed ID: 20600707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Golfer exposure to chlorpyrifos and carbaryl following application to turfgrass.
    Putnam RA; Doherty JJ; Clark JM
    J Agric Food Chem; 2008 Aug; 56(15):6616-22. PubMed ID: 18598045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstructing exposures from biomarkers using exposure-pharmacokinetic modeling--A case study with carbaryl.
    Brown K; Phillips M; Grulke C; Yoon M; Young B; McDougall R; Leonard J; Lu J; Lefew W; Tan YM
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):689-98. PubMed ID: 26545325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal error in biomarker-based mean exposure estimates for individuals.
    Bartell SM; Griffith WC; Faustman EM
    J Expo Anal Environ Epidemiol; 2004 Mar; 14(2):173-9. PubMed ID: 15014548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On modelling metabolism-based biomarkers of exposure: a comparative analysis of nonlinear models with few repeated measurements.
    Johnson BA; Rappaport SM
    Stat Med; 2007 Apr; 26(9):1901-19. PubMed ID: 17330247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations versus amounts of biomarkers in urine: a comparison of approaches to assess pyrethroid exposure.
    Fortin MC; Carrier G; Bouchard M
    Environ Health; 2008 Nov; 7():55. PubMed ID: 18983658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating measurement error in estimates of worker exposure assessed in parallel by personal and biological monitoring.
    Symanski E; Greeson NM; Chan W
    Am J Ind Med; 2007 Feb; 50(2):112-21. PubMed ID: 17238141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly.
    Evans MV; Chiu WA; Okino MS; Caldwell JC
    Toxicol Appl Pharmacol; 2009 May; 236(3):329-40. PubMed ID: 19249323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.